Clinical Trials Directory

Trials / Completed

CompletedNCT02149082

Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children

Status
Completed
Phase
Study type
Observational
Enrollment
465 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study to determine whether the Near infrared spectroscopy (NIRS) optical density (OD) measurement with an Infrascanner device accurately identifies the presence of an intracranial hematoma in pediatric patients ≤18 years of age after known or suspected traumatic brain injury compared with head computerized tomography (CT) scans as the gold standard.

Detailed description

A key decision point in the management of patients with an acute traumatic brain injury is determining the presence of an intracranial hematoma that may require neurosurgical intervention. An expanding hematoma can lead to significant neurological morbidity or death due to brainstem compression or further ischemic injury. Unfortunately, no single physical sign, symptom, or score reliably indicates the presence of an intracranial hematoma. A computerized tomography (CT) scan of the head is the gold standard for emergent identification and localization of acute intracranial hematomas. However, the ionizing radiation from CT scans is associated with an increased risk of developing malignancies. Near infrared spectroscopy (NIRS) is a non-invasive technology that may be useful as an adjunctive modality to CT scanning for early identification of intracranial hematomas. A hand-held NIRS device called the Infrascanner has shown about 90% sensitivity and specificity for detecting intracranial hematomas in adults and a few small studies have shown similar results in children. The present study will aim to validate this device in a wide age range of pediatric subjects and in multiple hospital settings where this device may serve as a valuable screening tool.

Conditions

Interventions

TypeNameDescription
DEVICEInfrascanner Model 2000The Infrascanner Model 2000 device is a small, portable handheld device that uses near infrared (NIR) technology to screen patients for intracranial bleeding.

Timeline

Start date
2014-06-01
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2014-05-29
Last updated
2018-11-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02149082. Inclusion in this directory is not an endorsement.